tm logo
CARTILAPS
Live/Registered
REGISTERED AND RENEWED

on 24 Jul 2024

Last Applicant/ Owned by

10 DIDCOT WAY

TYNE AND WEAR

GB

NE35 9PD

Serial Number

78151324 filed on 06th Aug 2002

Registration Number

2786373 registered on 25th Nov 2003

in the Principal Register

Correspondent Address

Kevan L. Morgan

Seed IP Law Group LLP

Suite 5400

Seattle, WA 98104

US

Filing Basis

1. intent to use

Disclaimer

NO DATA

CARTILAPS

IMMUNOASSAY PREPARATIONS, NAMELY, ANTIBODIES AND PROCESSING CHEMICALS FOR RESEARCH ON CELL CULTURES AND OTHER BIOLOGICAL SAMPLES IMMUNOASSAY PREPARATIONS, NAMELY, ANTIBODIES AND PROCESSING CHEMICALS FOR CLINICAL USE ON CELL CULTURES AND OTHER BIOLOGICAL SAMPLES

Classification Information


Class [005]
Pharmaceutical Products


IMMUNOASSAY PREPARATIONS, NAMELY, ANTIBODIES AND PROCESSING CHEMICALS FOR CLINICAL USE ON CELL CULTURES AND OTHER BIOLOGICAL SAMPLES


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


IMMUNOASSAY PREPARATIONS, NAMELY, ANTIBODIES AND PROCESSING CHEMICALS FOR RESEARCH ON CELL CULTURES AND OTHER BIOLOGICAL SAMPLES


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 78151324

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 480468.20001

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Jul 2024POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
24th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
24th Jul 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
24th Jul 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Mar 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
13th Mar 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Oct 2023TEAS SECTION 8 & 9 RECEIVED
25th Nov 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27th Jan 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th Dec 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED